Back to Journals » Journal of Hepatocellular Carcinoma » Volume 7

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


Archive: Volume 7, 2020

Potential Impact of IMbrave150 Results in the Evolving Treatment Landscape of Advanced Hepatocellular Carcinoma: A Multidisciplinary Expert Opinion

Kulik L, da Fonseca LG, He AR, Rimola J, Wilson Woods A, Zöllner YF, Galle PR

Journal of Hepatocellular Carcinoma 2020, 7:423-433

Published Date: 21 December 2020

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma

Zong J, Fan Z, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:413-422

Published Date: 18 December 2020

Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion

Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK

Journal of Hepatocellular Carcinoma 2020, 7:403-412

Published Date: 17 December 2020

Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant

Teng CF, Li TC, Wang T, Wu TH, Wang J, Wu HC, Shyu WC, Su IJ, Jeng LB

Journal of Hepatocellular Carcinoma 2020, 7:385-401

Published Date: 17 December 2020

Can Immediately Treating Subcentimeter Hepatocellular Carcinoma Improve the Survival of Patients?

Sun X, Hu D, Zhang Y, Lyu N, Xu L, Chen Q, Lai J, Chen M, Zhao M

Journal of Hepatocellular Carcinoma 2020, 7:377-384

Published Date: 16 December 2020

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma

Li M, Hu J, Jin R, Cheng H, Chen H, Li L, Guo K

Journal of Hepatocellular Carcinoma 2020, 7:361-376

Published Date: 8 December 2020

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:337-345

Published Date: 1 December 2020

Value of Follow-Up Chest Computed Tomography in the Surveillance of Patients with Hepatocellular Carcinoma

Moawad AW, Elsayes KM, Benamar F, Rao K, Sun J, Szklaruk J

Journal of Hepatocellular Carcinoma 2020, 7:331-335

Published Date: 18 November 2020

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma – A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

Jensen C, Holm Nielsen S, Eslam M, Genovese F, Nielsen MJ, Vongsuvanh R, Uchila R, van der Poorten D, George J, Karsdal MA, Leeming DJ, Willumsen N

Journal of Hepatocellular Carcinoma 2020, 7:301-313

Published Date: 9 November 2020

Association of the Pretreatment Lung Immune Prognostic Index with Survival Outcomes in Advanced Hepatocellular Carcinoma Patients Treated with PD-1 Inhibitors

Chen S, Huang Z, Jia W, Tao H, Zhang S, Ma J, Liu Z, Wang J, Wang L, Cui P, Zhang Z, Huang D, Wu Z, Zheng X, Hu Y

Journal of Hepatocellular Carcinoma 2020, 7:289-299

Published Date: 2 November 2020

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma

Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:271-288

Published Date: 29 October 2020

miR-3 Encoded by Hepatitis B Virus Downregulates PTEN Protein Expression and Promotes Cell Proliferation

Tang J, Xiao XQ, Jiang Y, Tian Y, Peng Z, Yang M, Xu Z, Gong G

Journal of Hepatocellular Carcinoma 2020, 7:257-269

Published Date: 29 October 2020

Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

Liu M, Wu R, Liu X, Xu H, Chi X, Wang X, Zhan M, Wang B, Peng F, Gao X, Shi Y, Wen X, Ji Y, Jin Q, Niu J

Journal of Hepatocellular Carcinoma 2020, 7:219-232

Published Date: 23 October 2020

Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization

Kobayashi S, Tajiri K, Murayama A, Entani T, Futsukaichi Y, Nagata K, Takahashi K, Yasuda I

Journal of Hepatocellular Carcinoma 2020, 7:181-189

Published Date: 14 October 2020

Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization

Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN

Journal of Hepatocellular Carcinoma 2020, 7:155-158

Published Date: 28 September 2020

Prognostic Significance of Serum Insulin-Like Growth Factor-1 in Hepatocellular Cancer Patients: A Validation Study

Lacin S, Yalcin S, Karakas Y, Hassan MM, Amin H, Mohamed YI, Rashid A, Morris JS, Xiao L, Qayyum A, Kaseb AO

Journal of Hepatocellular Carcinoma 2020, 7:143-153

Published Date: 16 September 2020

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

Teyateeti A, Mahvash A, Long JP, Abdelsalam ME, Avritscher R, Chasen B, Kaseb AO, Kuban JD, Murthy R, Odisio BC, Teyateeti A, Macapinlac HA, Kappadath SC

Journal of Hepatocellular Carcinoma 2020, 7:117-131

Published Date: 14 September 2020

Resection of NAFLD-Associated HCC: Patient Selection and Reported Outcomes

Campani C, Bensi C, Milani S, Galli A, Tarocchi M

Journal of Hepatocellular Carcinoma 2020, 7:107-116

Published Date: 30 July 2020

Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging

Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM

Journal of Hepatocellular Carcinoma 2020, 7:77-89

Published Date: 23 April 2020

Rare Site Hepatocellular Carcinoma Metastasis

Boldo E, Santafe A, Mayol A, Lozoya R, Coret A, Escribano D, Fortea-Sanchis C, Muñoz A, Pastor JC, Perez de Lucia G, Bosch N

Journal of Hepatocellular Carcinoma 2020, 7:39-44

Published Date: 25 March 2020

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2

Liu T, Li S, Wu L, Yu Q, Li J, Feng J, Zhang J, Chen J, Zhou Y, Ji J, Chen K, Mao Y, Wang F, Dai W, Fan X, Wu J, Guo C

Journal of Hepatocellular Carcinoma 2020, 7:19-31

Published Date: 18 February 2020

Exploring Metabolic Consequences of CPS1 and CAD Dysregulation in Hepatocellular Carcinoma by Network Reconstruction

Dumenci OE, U AMR, Khan SA, Holmes E, Taylor-Robinson SD

Journal of Hepatocellular Carcinoma 2020, 7:1-9

Published Date: 7 January 2020